Bavelloni, Alberto, Manuela Piazzi, Giulia Ramazzotti, Roberta Fiume, William Blalock, and Irene Faenza. 2017. “PI3Kα-Selective Inhibitor Alpelisib (BYL719), May Be Effective As Anticancer Agents in Rhabdomyosarcoma”. Italian Journal of Anatomy and Embryology 122 (1):21. https://oajournals.fupress.net/index.php/ijae/article/view/1730.